MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

105.25

-0.38%↓

WBA

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

105.25

-0.38%↓

WBA

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

105.25

-0.38%↓

WBA

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

105.25

-0.38%↓

WBA

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

105.25

-0.38%↓

WBA

+0.36%↑

CHE

545.53

-2.68%↓

Home・Akcijų sąrašas・Novavax Inc

Novavax Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

7.11 1.14

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

6.81

Max

7.09

Pagrindiniai rodikliai
By Trading Economics
Pajamos	40M -81M
Pardavimai	3.8M 88M
Pelnas, tenkantis vienai akcijai	-0.52
Pelno marža	-91.755
Darbuotojai	952
EBITDA	52M -53M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+101.56% upside

Dividendai
By Dow Jones
Kitas uždarbis	2025-05-09

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-299M 967M
Ankstesnė atidarymo kaina	5.97
Ankstesnė uždarymo kaina	7.11

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bullish Evidence

5.6 / 6.467 Palaikymas ir pasipriešinimas

Novavax Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-04-02 17:06; UTC

Pagrindinės rinkos jėgos

Novavax Falls But Then Recovers After WSJ Report on Vaccine's FDA Status

2025-03-31 14:19; UTC

Pagrindinės rinkos jėgos

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

2025-02-04 18:52; UTC

Pagrindinės rinkos jėgos

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

2024-11-11 14:05; UTC

Pagrindinės rinkos jėgos

Novavax to Move Forward With Covid-19, Influenza Vaccine After FDA Lifts Clinical Hold

2024-10-16 12:59; UTC

Pagrindinės rinkos jėgos

Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines; Shares Drop

2024-05-13 18:14; UTC

Pagrindinės rinkos jėgos

Novavax Shares Pop Another 50% Following Sanofi Deal

2024-05-10 10:59; UTC

Pagrindinės rinkos jėgos

Novavax Shares Surge on $1.4 Billion Vaccine Licensing Deal with Sanofi

2024-12-30 23:02; UTC

Įsigijimai, susijungimai, perėmimai

Novavax Completes Previously Announced $200M Sale of Czech Republic Manufacturing Site to Novo Nordisk

2024-12-04 07:09; UTC

Įsigijimai, susijungimai, perėmimai

Novavax: Agreement to Close by Dec 30 >NVAX

2024-12-04 07:08; UTC

Įsigijimai, susijungimai, perėmimai

Novavax: Sale Aligns With Plan to Become More Lean Organization, Drive Value From Pipeline Assets & Tech Platform >NVAX

2024-12-04 07:07; UTC

Įsigijimai, susijungimai, perėmimai

Novavax: Deal to Also Reduce Annual Operating Costs by About $80M >NVAX

2024-12-04 07:06; UTC

Įsigijimai, susijungimai, perėmimai

Novavax to Get $190M Cash Payment in 2024, Additional $10M in 2025 >NVAX

2024-12-04 07:06; UTC

Įsigijimai, susijungimai, perėmimai

Novavax: Agreement Provides Company With Significant, Non-Dilutive Capital >NVAX

2024-12-04 07:04; UTC

Įsigijimai, susijungimai, perėmimai

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200M

2024-11-15 13:34; UTC

Svarbiausios naujienos

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ

2024-11-15 11:14; UTC

Rinkos pokalbiai

U.S. Vaccine Stocks Fall After Trump Picks Vaccine Skeptic RFK Jr as Health Department Head-- Market Talk

2024-10-16 15:22; UTC

Uždarbis

These Stocks Are Moving the Most Today: ASML, Nvidia, Morgan Stanley, United Airlines, DJT, Novavax, J.B. Hunt, Cisco, and More -- Barrons.com

2024-05-10 20:11; UTC

Uždarbis

These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital, JFrog, SoundHound, and More -- Barrons.com

2024-05-10 14:49; UTC

Uždarbis

Karštos akcijos

Stocks to Watch Friday: TSMC, Novavax, Nvidia -- WSJ

2024-05-10 10:47; UTC

Įsigijimai, susijungimai, perėmimai

Novavax Gets $1.4 Billion Deal With Sanofi. The Stock Jumps. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Novavax Inc Prognozė

Kainos tikslas

By TipRanks

101.56% į viršų

12 mėnesių prognozė

Vidutinis 14.25 USD 101.56%

Aukščiausias 19 USD

Žemiausias 9 USD

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Novavax Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

4 ratings

Pirkti

Laikyti

Parduoti

Remiantis 4 analitikų, pateikusių Novavax Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

5.6 / 6.467Palaikymas ir pasipriešinimas

Recent bullish events outweigh bearish events.

All events are bearish.

Bearish events outweigh bullish events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.